Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321(3):288–300.

Article  CAS  PubMed  Google Scholar 

Jiang Z-R, Yang L-H, Jin L-Z, Yi L-M, Bing P-P, Zhou J, et al. Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients. Front Oncol. 2022;12:988680.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iranshahi N, Zafari P, Yari K, Alizadeh E. The most common genes involved in epigenetics modifications among Iranian patients with breast cancer: a systematic review. Cell Mol Biol. 2016;62(12):116–22.

CAS  PubMed  Google Scholar 

Batlle E, Massagué J. Transforming growth factor-β signaling in immunity and cancer. Immunity. 2019;50(4):924–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao J, Liu Y, Zhu L, Li J, Liu Y, Luo J, et al. Tumor cell membrane-coated continuous electrochemical sensor for GLUT1 inhibitor screening. J Pharm Anal. 2023. https://doi.org/10.1016/j.jpha.2023.04.015.

Article  PubMed  PubMed Central  Google Scholar 

Chen S, Chen Y, Yu L, Hu X. Overexpression of SOCS4 inhibits proliferation and migration of cervical cancer cells by regulating JAK1/STAT3 signaling pathway. Eur J Gynaecol Oncol. 2021;42(3):554–60.

Article  Google Scholar 

Wang X, Qi Y, Kong X, Zhai J, Li Y, Song Y, et al. Immunological therapy: a novel thriving area for triple-negative breast cancer treatment. Cancer Lett. 2019;442:409–28.

Article  CAS  PubMed  Google Scholar 

Chang Q-Q, Chen C-Y, Chen Z, Chang S. LncRNA PVT1 promotes proliferation and invasion through enhancing Smad3 expression by sponging miR-140-5p in cervical cancer. Radiol Oncol. 2019;53(4):443.

Article  PubMed  PubMed Central  Google Scholar 

Shen W, Pei P, Zhang C, Li J, Han X, Liu T, et al. A polymeric hydrogel to eliminate programmed death-ligand 1 for enhanced tumor radio-immunotherapy. ACS Nano. 2023. https://doi.org/10.1021/acsnano.3c08875.

Article  PubMed  PubMed Central  Google Scholar 

Ye X-X, Ren Z-Y, Vafaei S, Zhang J-M, Song Y, Wang Y-X, et al. Effectiveness of Baduanjin exercise on quality of life and psychological health in postoperative patients with breast cancer: a systematic review and meta-analysis. Integr Cancer Ther. 2022. https://doi.org/10.1177/15347354221104092.

Article  PubMed  PubMed Central  Google Scholar 

Pasero C, Speiser DE, Derre L, Olive D. The HVEM network: new directions in targeting novel costimulatory/co-inhibitory molecules for cancer therapy. Curr Opin Pharmacol. 2012;12(4):478–85.

Article  CAS  PubMed  Google Scholar 

Xu H, Wang H, Zhao W, Fu S, Li Y, Ni W, et al. SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma. Theranostics. 2020;10(13):5671.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cai G, Anumanthan A, Brown JA, Greenfield EA, Zhu B, Freeman GJ. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol. 2008;9(2):176–85.

Article  CAS  PubMed  Google Scholar 

Sedy JR, Gavrieli M, Potter KG, Hurchla MA, Lindsley RC, Hildner K, et al. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol. 2005;6(1):90–8.

Article  CAS  PubMed  Google Scholar 

Pan L, Feng F, Wu J, Fan S, Han J, Wang S, et al. Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells. Pharmacol Res. 2022;181:106270.

Article  CAS  PubMed  Google Scholar 

Cheung TC, Steinberg MW, Oborne LM, Macauley MG, Fukuyama S, Sanjo H, et al. Unconventional ligand activation of herpesvirus entry mediator signals cell survival. Proc Natl Acad Sci. 2009;106(15):6244–9.

Article  CAS  PubMed  PubMed Central  ADS  Google Scholar 

Akbari M, Elmi R. Herpes simplex virus and human papillomavirus coinfections in hyperimmunoglobulin E syndrome presenting as a conjunctival mass lesion. Case Rep Med. 2017. https://doi.org/10.1155/2017/1650841.

Article  PubMed  PubMed Central  Google Scholar 

Akbarian A, Shahhosseiny MH, Vafaei S, Moslemi E, Ghahri M. Designing novel and simple competitive internal amplification control for reliable PCR diagnosis of herpes simplex virus. Jundishapur J Microbiol. 2015. https://doi.org/10.5812/jjm.16260.

Article  PubMed  PubMed Central  Google Scholar 

Shaikh RB, Santee S, Granger SW, Butrovich K, Cheung T, Kronenberg M, et al. Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J Immunol. 2001;167(11):6330–7.

Article  CAS  PubMed  Google Scholar 

Harrop JA, McDonnell PC, Brigham-Burke M, Lyn SD, Minton J, Tan K, et al. Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J Biol Chem. 1998;273(42):27548–56.

Article  CAS  PubMed  Google Scholar 

Tsang JY, Chan K-W, Ni Y-B, Hlaing T, Hu J, Chan S-K, et al. Expression and clinical significance of herpes virus entry mediator (HVEM) in breast cancer. Ann Surg Oncol. 2017;24:4042–50.

Article  PubMed  Google Scholar 

Inoue T, Sho M, Yasuda S, Nishiwada S, Nakamura S, Ueda T, et al. HVEM expression contributes to tumor progression and prognosis in human colorectal cancer. Anticancer Res. 2015;35(3):1361–7.

PubMed  Google Scholar 

Migita K, Sho M, Shimada K, Yasuda S, Yamato I, Takayama T, et al. Significant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinoma. Cancer. 2014;120(6):808–17.

Article  CAS  PubMed  Google Scholar 

Oh D-Y, Bang Y-J. HER2-targeted therapies—a role beyond breast cancer. Nat Rev Clin Oncol. 2020;17(1):33–48.

Article  CAS  PubMed  Google Scholar 

Capelan M, Pugliano L, De Azambuja E, Bozovic I, Saini K, Sotiriou C, et al. Pertuzumab: new hope for patients with HER2-positive breast cancer. Ann Oncol. 2013;24(2):273–82.

Article  CAS  PubMed  Google Scholar 

Sakai K, Yokote H, Murakami-Murofushi K, Tamura T, Saijo N, Nishio K. Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway. Cancer Sci. 2007;98(9):1498–503.

Article  CAS  PubMed  Google Scholar 

Darvin P, Toor SM, Sasidharan Nair V, Elkord E. Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp Mol Med. 2018;50(12):1–11.

Article  PubMed  Google Scholar 

Polk A, Svane I-M, Andersson M, Nielsen D. Checkpoint inhibitors in breast cancer–current status. Cancer Treat Rev. 2018;63:122–34.

Article  CAS  PubMed  Google Scholar 

Heimes A-S, Schmidt M. Atezolizumab for the treatment of triple-negative breast cancer. Expert Opin Investig Drugs. 2019;28(1):1–5.

Article  CAS  PubMed  Google Scholar 

Rosenberg JE, Hoffman-Censits J, Powles T, Van Der Heijden MS, Balar AV, Necchi A, et al. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Lancet. 2016;387(10031):1909–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Naidoo J, Cappelli LC, Forde PM, Marrone KA, Lipson EJ, Hammers HJ, et al. Inflammatory arthritis: a newly recognized adverse event of immune checkpoint blockade. Oncologist. 2017;22(6):627–30.

Article  PubMed  PubMed Central  Google Scholar 

Norouzi M, Rezvankhah B, Haeri MR, Heydari H, Tafaroji J, Shafigh N, et al. Magnesium supplementation and insulin resistance in patients with rheumatoid arthritis. Eur J Transl Myol. 2022. https://doi.org/10.4081/ejtm.2022.10622.

Article  PubMed  PubMed Central  Google Scholar 

Khodadadi S, Dakhili M, Akhlaghi L, Haeri MR, Tabatabaie F. Three-year epidemiological evaluation of cutaneous leishmaniasis in Qom province (2007–2009). HealthMED. 2012;6(9):3056–60.

Google Scholar 

Franklin C, Livingstone E, Roesch A, Schilling B, Schadendorf D. Immunotherapy in melanoma: recent advances and future directions. Eur J Surg Oncol. 2017;43(3):604–11.

Article  CAS  PubMed  Google Scholar 

Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Yang T-HO, et al. The immune landscape of cancer. Immunity. 2018;48(4):812–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Netanely D, Avraham A, Ben-Baruch A, Evron E, Shamir R. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups. Breast Cancer Res. 2016;18(1):1–16.